首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   10577篇
  免费   1291篇
  国内免费   206篇
耳鼻咽喉   12篇
儿科学   6篇
妇产科学   2篇
基础医学   575篇
口腔科学   41篇
临床医学   1307篇
内科学   1811篇
皮肤病学   5篇
神经病学   5235篇
特种医学   112篇
外科学   97篇
综合类   905篇
一般理论   6篇
预防医学   723篇
眼科学   24篇
药学   533篇
  2篇
中国医学   661篇
肿瘤学   17篇
  2024年   42篇
  2023年   287篇
  2022年   255篇
  2021年   395篇
  2020年   499篇
  2019年   549篇
  2018年   482篇
  2017年   526篇
  2016年   458篇
  2015年   418篇
  2014年   619篇
  2013年   841篇
  2012年   539篇
  2011年   562篇
  2010年   472篇
  2009年   481篇
  2008年   500篇
  2007年   480篇
  2006年   415篇
  2005年   394篇
  2004年   338篇
  2003年   343篇
  2002年   335篇
  2001年   238篇
  2000年   160篇
  1999年   113篇
  1998年   142篇
  1997年   157篇
  1996年   134篇
  1995年   105篇
  1994年   96篇
  1993年   87篇
  1992年   92篇
  1991年   87篇
  1990年   58篇
  1989年   64篇
  1988年   49篇
  1987年   38篇
  1986年   34篇
  1985年   55篇
  1984年   30篇
  1983年   26篇
  1982年   26篇
  1981年   22篇
  1980年   8篇
  1979年   8篇
  1978年   4篇
  1977年   3篇
  1976年   3篇
  1974年   2篇
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
21.
针灸对血管性痴呆患者相关量表积分的影响   总被引:8,自引:0,他引:8  
目的 :观察针灸治疗血管性痴呆 (VD)的疗效。方法 :选用针灸百会、人中、涌泉、神门、大钟等穴治疗血管性痴呆患者 17例 ,并于治疗前后测定MMSE R、ADL R及BBS量表。结果 :针灸对痴呆患者的MMSE R、ADL R以及BBS中生活能力量表积分有明显改善作用 (P <0 .0 1) ,而对BBS中日常习惯及个性改变的量表积分影响不显著 (P >0 .0 5 )。结论 :针灸治疗VD疗效确切 ,能提高VD患者生活质量  相似文献   
22.
目的观察葛根素对血管性痴呆(VaD)患者认知功能和听觉事件相关电位P300的影响。方法将70例VaD患者随机分成两组各35例,葛根素治疗组和对照组。应用简易精神状态检查量表(MMSE)评定两组患者治疗前后认知功能状况,并进行治疗前后P300检查。同时记录药物不良反应。结果两组各35例进入结果分析。治疗前两组MMSE评分、P300的潜伏期及波幅差异无显著性(均P〉0.05)。治疗14d、30d时,两组MMSE评分显著提高(均P〈0.01),P300潜伏期均有缩短,波幅均有提高(葛根素组P〈0.01,对照组P〈0.05);治疗后14d时认知功能改善葛根素组明显优于对照组(总有效率分别为91.4%,71.4%)(P〈0.05)。两组治疗期间无严重不良反应。结论葛根素能够改善VaD患者的认知功能,这可能与葛根素的扩血管、脑保护作用有关。  相似文献   
23.
目的 观察益气复智颗粒对多发脑梗死性痴呆模型大鼠脑皮质形态学、细胞凋亡的影响。方法 采用颈内动脉注射血栓的方法,复制多发梗死性痴呆大鼠模型,观察益气复智颗粒12.42g/kg分别于手术前、手术前后、手术后灌胃对实验动物脑皮质形态学、细胞凋亡的影响。结果 益气复智颗粒能使脑缺血后脑内神经细胞凋亡数目下降。结论 益气复智颗粒具有较好的保护脑神经元,阻断脑缺血致神经细胞死亡病理过程的作用。  相似文献   
24.
清开灵注射液治疗脑血管性痴呆32例   总被引:9,自引:0,他引:9  
目的观察清开灵注射液治疗脑血管性痴呆的疗效.方法将中医学辨证属于实证的64例脑血管性痴呆患者随机分为治疗组(清开灵注射液组)和对照组(脑复康组),治疗5周后,将两组治疗前后在智力障碍程度、肢体功能、血液流变学指标、中医证型疗效方面的变化进行比较.结果经治疗后治疗组和对照组相比较,智力障碍程度变化(有效率、MMSE、ADL积分)、肌力、步行能力改变有显著性差异,p<0.05.而治疗前后组内及组间血流变指标虽有一定下降,但无统计学意义(p>0.05).结论清开灵注射液对脑血管性痴呆患者,在改善智力障碍、肌力、步行能力方面有较好的疗效.  相似文献   
25.
The concept of need and the practice of needs assessment are both subject to a wide range of interpretations, to the likely detriment of individual assessments and to multidisciplinary working. Clear definition is important for individual assessment, for the development of multidisciplinary tools and in gathering planning information. The concept of need is clarified, firstly by distinguishing between need and the difficulties that engender it, and secondly through a taxonomy of need. These assist clear definitions of both need and needs assessment when linked with a consideration of the current help a person receives and a specification of the type of help required by a person to meet their needs. Such definitions have implications for the role of needs assessment in individual assessment, service evaluation, service management and planning and in the development of multidisciplinary needs assessment tools.  相似文献   
26.
醒脑启智胶囊对学习记忆障碍小鼠行为的影响   总被引:4,自引:2,他引:2  
目的观察醒脑启智胶囊对血管性痴呆学习记忆障碍小鼠行为的影响 ,验证醒脑启智胶囊对血管性痴呆的疗效。方法复制脑缺血再灌注血管性痴呆小鼠模型 ,灌胃给药 ,并与银杏叶、尼莫地平对照 ,分别于术后 7天、15天、3 0天 ,采用水迷宫法检测各组小鼠行为学变化。结果模型小鼠学习与记忆能力下降 ,表现为游全程时间延长 ,错误次数增加。醒脑启智胶囊可使模型小鼠游全程时间缩短 ,错误次数减少 ,优于对照药物。结论醒脑启智胶囊对模型小鼠学习与记忆能力下降有提高作用。  相似文献   
27.
We report a case of a 68‐year‐old right‐handed man with sporadic amyotrophic lateral sclerosis (ALS) and argyrophilic grain disease (AGD) having a 22‐month duration. His initial symptoms were dysarthria and swallowing difficulty at the age of 67. Subsequently bulbar palsy and pyramidal signs developed. His cognitive functions including face recognition, personality, and behavior were not changed compared with that of before the disease onset. However, magnetic resonance imaging disclosed severe right side‐predominant temporal atrophy. The neurological diagnosis was bulbar type ALS. Pathological examination disclosed histological evidence of ALS, including loss of Betz cells and lower motor neurons, corticospinal tract degeneration, and Bunina bodies. In addition, severe neuronal loss in the bilateral temporal cortex with an anterior gradient was found. Ubiquitin‐positive inclusions were encountered in the spinal anterior horn cells and hippocampal dentate gyrus, while few ubiquitin‐positive inclusions were noted in the affected temporal cortex. The amygdala, especially the basolateral nuclear group, was severely affected by neuronal loss with tissue rarefaction. Moderate neuronal loss was encountered in the parahippocampal gyrus, and to a lesser degree, in the ambient gyrus. Unexpectedly, many argyrophilic grains, coiled bodies, tau‐positive bush‐like astrocytes, pretangles, and ballooned neurons were found in the limbic system and temporal cortex. In the hippocampus, selective tau accumulation with minor neurofibrillary changes was observed in CA2 neurons. The present case suggests that (i) ALS and AGD do rarely coexist, and (ii) when ALS patients have severe temporal atrophy, not only ALS with dementia but also concurrent AGD should be considered in the differential diagnosis.  相似文献   
28.
Background: Progression of the core and accessory symptoms of dementia can be slowed if drug therapies and psychosocial interventions are administered at an early stage. The aim of this study was to develop and standardize a neuropsychological test for the elderly that can detect dementia at an early stage with high sensitivity and can evaluate a wide range of severities of dementia based on assessments of various cognitive functions. Methods: A preliminary test consisting of 23 items and the Nishimura Mental State Scale for the Elderly (NM Scale), which evaluates the mental functions of elderly individuals by observing their actual behaviors in daily life, were administered to 448 elderly subjects. After applying Hayashi’s quantification theory type I to the results, we revised the preliminary test to construct a neuropsychological test for the elderly, which we named the Nishimura Dementia Test (ND Test), and standardized it. Then, we examined its validity and test–retest reliability. Results: Among the 448 subjects, there was a strong correlation between the ND Test scores and NM Scale scores. The ND Test showed a good general agreement rate for the discrimination of the severity of dementia, and good sensitivity and specificity of discrimination of dementia when compared with the actual NM Scale. Using different groups of elderly subjects, the ND Test showed validity and test–retest reliability, and the ND Test scores showed strong correlations with the Revised Hasegawa Dementia Scale scores and the Mini‐Mental State Examination scores. Conclusions: The ND Test is based on assessment of a variety of cognitive functions and can evaluate a wide range of severities of dementia with good validity and reliability.  相似文献   
29.
30.
老年期痴呆抑郁和焦虑障碍共病研究   总被引:3,自引:0,他引:3  
目的:了解老年期痴呆患者抑郁和焦虑障碍共病率及其相关因素。方法:将100例老年期痴呆患者分为两组,阿尔茨海默病(AD)组和血管性痴呆(VD)组。用简明精神病评定量表(BPRS)、Hamilton抑郁量表(HAMD)、Hamilton焦虑量表(HAMA)进行评定。结果:AD组有焦虑20例,伴抑郁17例;VD组有焦虑17例,伴抑郁15例。共病28例,AD组与VD组各14例。AD组与VD组在HAMD因子分有明显差异(P〈0.05)。结论:老年期痴呆患者抑郁和焦虑共病率较高,应引起高度重视。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号